US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist
  • 7.380
  • -0.360-4.65%
Trading May 2 09:35 ET
2.29BMarket Cap-19.42P/E (TTM)

About Amneal Pharmaceuticals Company

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolAMRX
Company NameAmneal Pharmaceuticals
Listing DateMay 7, 2018
Founded2002
CEOMr. Robert A. Stewart
MarketNASDAQ
Employees8100
Fiscal Year Ends12-31
Address400 Crossing Boulevard,3rd floor
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807
Phone1-908-947-3120

Company Executives

  • Name
  • Position
  • Salary
  • Chirag Patel
  • Director, Co-Chief Executive Officer and President
  • 7.19M
  • Chintu Patel
  • Director and Co-Chief Executive Officer
  • 7.19M
  • Nikita Shah
  • Executive Vice President and Chief Human Resources Officer
  • 2.37M
  • Jason B. Daly
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 2.38M
  • Andrew S. Boyer
  • Executive Vice President and Chief Commercial Officer, Generics
  • 2.79M
  • Anastasios G. Konidaris
  • Principal Accounting Officer, Executive Vice President and Chief Financial Officer
  • 2.85M
  • Paul M. Meister
  • Chairman of the Board
  • 450.00K
  • Emily Peterson Alva
  • Independent Director
  • 336.91K
  • Deborah M. Autor
  • Independent Director
  • 365.00K
  • Ted C. Nark
  • Independent Director
  • 352.50K
  • Shlomo Yanai
  • Independent Director
  • 360.00K
  • John J. Kiely, Jr
  • Independent Director
  • 380.00K
  • Jeffrey P. George
  • Independent Director
  • 375.00K
  • J. Kevin Buchi
  • Independent Director
  • 389.17K
  • Gautam Patel
  • Independent Director
  • 325.00K

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More